Herschel Mukherjee

Title: Innovations of Herschel Mukherjee in Nucleic Acid-Binding Photoprobes

Introduction

Herschel Mukherjee is an accomplished inventor based in Somerville, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of photoprobes that interact with nucleic acids. His work focuses on advancing our understanding of RNA transcripts and their potential as drug targets.

Latest Patents

Herschel Mukherjee holds a patent for "Nucleic acid-binding photoprobes and uses thereof." This invention relates to photoactivatable compounds and methods for determining binding sites and structural information about RNA transcripts. The patent outlines innovative methods for identifying RNA transcripts that bind to compounds, which can lead to druggable targets. Additionally, it provides techniques for screening drug candidates and determining drug binding sites on target RNA.

Career Highlights

Herschel is currently employed at Arrakis Therapeutics, Inc., where he continues to explore the therapeutic potential of RNA-targeted drugs. His work at Arrakis Therapeutics emphasizes the importance of RNA in drug discovery and development.

Collaborations

Herschel has collaborated with notable colleagues, including Gnanasambandam Kumaravel and Jennifer C. Petter. These collaborations have further enriched his research and contributed to advancements in the field.

Conclusion

Herschel Mukherjee's innovative work in nucleic acid-binding photoprobes exemplifies the intersection of chemistry and biology. His contributions are paving the way for new therapeutic strategies targeting RNA, which could have a profound impact on drug development.